Management of Pain with Swallowing in Severe Allergic Rhinitis
Primary Treatment Approach
- The American Academy of Allergy, Asthma, and Immunology recommends initiating intranasal corticosteroid immediately at 200 mcg daily as the most effective monotherapy for controlling all major symptoms of allergic rhinitis, including postnasal drainage that causes throat pain 1
- Intranasal corticosteroids are the single most effective medication class for controlling rhinorrhea and postnasal drainage, which are the primary drivers of pharyngeal irritation and odynophagia in allergic rhinitis patients, with a high level of evidence supporting their use 2, 3
Adjunctive Measures
- Implementing nasal saline irrigation can mechanically remove postnasal secretions and allergens from the posterior pharynx, directly addressing the irritation causing odynophagia, as recommended by the American College of Allergy, Asthma, and Immunology 1
- The American Academy of Otolaryngology recommends avoiding oral antihistamines as monotherapy for this presentation, as they have minimal effect on nasal congestion and postnasal drainage, which are the root causes of the throat pain, with a moderate level of evidence supporting this recommendation 1, 4
Critical Pitfalls to Avoid
- The American Academy of Allergy, Asthma, and Immunology advises never using topical decongestants for more than 3 days to avoid rhinitis medicamentosa, which will worsen the underlying condition and perpetuate throat symptoms, with a high level of evidence supporting this recommendation 3, 4
- Directing the intranasal corticosteroid spray away from the nasal septum can prevent mucosal erosions and potential septal perforation, as recommended by the American Rhinologic Society 3, 1
When to Escalate Care
- The American College of Allergy, Asthma, and Immunology recommends referring to an allergist/immunologist if symptoms remain inadequately controlled after 4-7 days of optimal intranasal corticosteroid therapy, as allergen immunotherapy may be indicated, with a moderate level of evidence supporting this recommendation 1
- Evaluating for comorbid conditions, including sinusitis, asthma, or eustachian tube dysfunction, may require additional management, as recommended by the American Academy of Allergy, Asthma, and Immunology, with a low level of evidence supporting this recommendation 2